Zeria Gets PMS Drug Prefemin Approved In Japan
This article was originally published in PharmAsia News
Executive Summary
Zeria has obtained manufacturing and marketing approval in Japan for its postmenstrual syndrome drug Prefemin.
You may also be interested in...
QUOTED. 22 October. Robert Ford.
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
China Regulatory Express: Biosecurity Law, Export Controls And The Life Science Sector
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Mediocre Vaccine Could Make Pandemic Worse, Non-Profit Group Tells US FDA
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports